If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 1991-1996 Ph.D., University of Maryland School of Medicine, USA
  • 1982-1989 M.D., Faculty of Medicine, National Yang-Ming University

Experience

  • Vice Superintendent of Taipei Medical University Hospital
  • 2019.08- Director,  International Ph.D. Program for Cell Therapy and Regeneration Medicine, Taipei Medical University
  • 2018.08- Professor, International Ph.D. Program for Cell Therapy and Regeneration Medicine, Taipei Medical University
  • 2017.09- Professor, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University
  • 2012.07-2017.03 Vice Superintendent, Chang Gung Memorial Hospital
  • 2009.07-2012.06 Minister, Department of Internal Medicine, Chang Gung Memorial Hospital, Chiayi
  • 2004.04-2017.03 Attending Physician, Division of Hematology & Oncology, Chang Gung Memorial Hospital, Chiayi

Awards

  • 2019 Affiliated Hospital Research Project Award, Taipei Medical University

Research Interests

  • immune cell therapy

Fingerprint Dive into the research topics where Kuan-Der Lee is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 18 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

癌症病人免疫治療前後之免疫監測

Lee, K.

1/1/1912/1/19

Project: A - Government Institutiond - Ministry of Education

Research Output

  • 3731 Citations
  • 25 h-Index
  • 91 Article
  • 4 Letter
  • 2 Review article
Open Access
  • Open Access
  • Open Access
  • Antrodia cinnamomea extract inhibits the proliferation of tamoxifen-resistant breast cancer cells through apoptosis and skp2/microRNAs pathway

    Lin, Y. S., Lin, Y. Y., Yang, Y. H., Lin, C. L., Kuan, F. C., Lu, C. N., Chang, G. H., Tsai, M. S., Hsu, C. M., Yeh, R. A., Yang, P. R., Lee, I. Y., Shu, L. H., Cheng, Y. C., Liu, H. T., Lee, K. D., Chang, D. C. & Wu, C. Y., May 9 2018, In : BMC Complementary and Alternative Medicine. 18, 1, 152.

    Research output: Contribution to journalArticle

  • 14 Citations (Scopus)

    A phase II study of S-1 plus oral leucovorin in heavily treated metastatic colorectal cancer patients

    Hsu, H. C., Chou, W. C., Kuan, F. C., Lee, K. D., Rau, K. M., Huang, J. S. & Yang, T. S., Jan 1 2018, In : Cancer Management and Research. 10, p. 6061-6070 10 p.

    Research output: Contribution to journalArticle

  • 2 Citations (Scopus)